These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 31724892

  • 1. CDKN2B-AS1 Exerts Oncogenic Role in Osteosarcoma by Promoting Cell Proliferation and Epithelial to Mesenchymal Transition.
    Luo Y, Tao H, Jin L, Xiang W, Guo W.
    Cancer Biother Radiopharm; 2020 Feb; 35(1):58-65. PubMed ID: 31724892
    [Abstract] [Full Text] [Related]

  • 2. LncRNA AFAP1-AS1 promotes tumorigenesis and epithelial-mesenchymal transition of osteosarcoma through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway.
    Shi D, Wu F, Mu S, Hu B, Zhong B, Gao F, Qing X, Liu J, Zhang Z, Shao Z.
    J Exp Clin Cancer Res; 2019 Aug 23; 38(1):375. PubMed ID: 31443665
    [Abstract] [Full Text] [Related]

  • 3. The Long Noncoding RNA ZEB2-AS1 Contributes to Proliferation and Epithelial-to-Mesenchymal Transition of Osteosarcoma.
    Yang J, Zou Y, Wu J, Chen B, Luo C, Chen X, Shen H, Luo L.
    Cancer Biother Radiopharm; 2023 Nov 23; 38(9):596-603. PubMed ID: 33085924
    [Abstract] [Full Text] [Related]

  • 4. LncRNA CDKN2B-AS1/miR-141/cyclin D network regulates tumor progression and metastasis of renal cell carcinoma.
    Dasgupta P, Kulkarni P, Majid S, Hashimoto Y, Shiina M, Shahryari V, Bhat NS, Tabatabai L, Yamamura S, Saini S, Tanaka Y, Dahiya R.
    Cell Death Dis; 2020 Aug 19; 11(8):660. PubMed ID: 32814766
    [Abstract] [Full Text] [Related]

  • 5. Long non-coding RNA CDKN2B-AS1 promotes osteosarcoma by increasing the expression of MAP3K3 via sponging miR-4458.
    Gui D, Cao H.
    In Vitro Cell Dev Biol Anim; 2020 Jan 19; 56(1):24-33. PubMed ID: 31950433
    [Abstract] [Full Text] [Related]

  • 6. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
    Yang W, Shan Z, Zhou X, Peng L, Zhi C, Chai J, Liu H, Yang J, Zhang Z.
    Cancer Biomark; 2018 Jan 19; 23(4):589-601. PubMed ID: 30475755
    [Abstract] [Full Text] [Related]

  • 7. LncRNA, CRNDE promotes osteosarcoma cell proliferation, invasion and migration by regulating Notch1 signaling and epithelial-mesenchymal transition.
    Li Z, Tang Y, Xing W, Dong W, Wang Z.
    Exp Mol Pathol; 2018 Feb 19; 104(1):19-25. PubMed ID: 29246789
    [Abstract] [Full Text] [Related]

  • 8. The lncRNA HNF1A-AS1 is a negative prognostic factor and promotes tumorigenesis in osteosarcoma.
    Cai L, Lv J, Zhang Y, Li J, Wang Y, Yang H.
    J Cell Mol Med; 2017 Nov 19; 21(11):2654-2662. PubMed ID: 28866868
    [Abstract] [Full Text] [Related]

  • 9. Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.
    Li C, Zhang S, Qiu T, Wang Y, Ricketts DM, Qi C.
    Cancer Biol Ther; 2019 Nov 19; 20(4):413-422. PubMed ID: 30489194
    [Abstract] [Full Text] [Related]

  • 10. Knockdown of long non-coding RNA HOXD-AS1 inhibits the progression of osteosarcoma.
    Qu Y, Zheng S, Kang M, Dong R, Zhou H, Zhao D, Zhao J.
    Biomed Pharmacother; 2018 Feb 19; 98():899-906. PubMed ID: 29571260
    [Abstract] [Full Text] [Related]

  • 11. FOXP4-AS1 participates in the development and progression of osteosarcoma by downregulating LATS1 via binding to LSD1 and EZH2.
    Yang L, Ge D, Chen X, Qiu J, Yin Z, Zheng S, Jiang C.
    Biochem Biophys Res Commun; 2018 Aug 25; 502(4):493-500. PubMed ID: 29859193
    [Abstract] [Full Text] [Related]

  • 12. Long Noncoding RNA SNHG7 Promotes the Tumor Growth and Epithelial-to-Mesenchymal Transition via Regulation of miR-34a Signals in Osteosarcoma.
    Deng Y, Zhao F, Zhang Z, Sun F, Wang M.
    Cancer Biother Radiopharm; 2018 Nov 25; 33(9):365-372. PubMed ID: 29989838
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of Long Non-Coding RNA NNT-AS1 Correlates with Tumor Progression and Poor Prognosis in Osteosarcoma.
    Ye H, Lin J, Yao X, Li Y, Lin X, Lu H.
    Cell Physiol Biochem; 2018 Nov 25; 45(5):1904-1914. PubMed ID: 29518771
    [Abstract] [Full Text] [Related]

  • 14. LncRNA ADPGK-AS1 regulated cell proliferation, invasion, migration and apoptosis via targeting miR-542-3p in osteosarcoma.
    Luo XF, Wu XJ, Wei X, Wang AG, Wang SH, Wang JL.
    Eur Rev Med Pharmacol Sci; 2019 Oct 25; 23(20):8751-8760. PubMed ID: 31696461
    [Abstract] [Full Text] [Related]

  • 15. Silencing of long noncoding RNA SBF2-AS1 inhibits proliferation, migration and invasion and contributes to apoptosis in osteosarcoma cells by upregulating microRNA-30a to suppress FOXA1 expression.
    Dai JH, Huang WZ, Li C, Deng J, Lin SJ, Luo J.
    Cell Cycle; 2019 Oct 25; 18(20):2727-2741. PubMed ID: 31432728
    [Abstract] [Full Text] [Related]

  • 16. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142.
    Zhang L, Zhao G, Ji S, Yuan Q, Zhou H.
    Med Sci Monit; 2020 Mar 10; 26():e921594. PubMed ID: 32155139
    [Abstract] [Full Text] [Related]

  • 17. The role and clinical significance of long noncoding RNA zinc finger E-box-binding homeobox two antisense RNA 1 in promoting osteosarcoma cancer cell proliferation, inhibiting apoptosis and increasing migration by regulating miR-145.
    Zhou Y, Feng D, Gu X, Gao A, Liu Y.
    Anticancer Drugs; 2021 Feb 01; 32(2):168-177. PubMed ID: 32826416
    [Abstract] [Full Text] [Related]

  • 18. Linc00460 promotes osteosarcoma progression via miR-1224-5p/FADS1 axis.
    Lian H, Xie P, Yin N, Zhang J, Zhang X, Li J, Zhang C.
    Life Sci; 2019 Sep 15; 233():116757. PubMed ID: 31419446
    [Abstract] [Full Text] [Related]

  • 19. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
    Song R, Zhang J, Huang J, Hai T.
    Cancer Biomark; 2018 Sep 15; 22(3):565-573. PubMed ID: 29843220
    [Abstract] [Full Text] [Related]

  • 20. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
    Liu ZB, Wang JA, Lv RQ.
    Eur Rev Med Pharmacol Sci; 2019 Feb 15; 23(4):1418-1427. PubMed ID: 30840262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.